Levicept   Report issue

For profit Phase 2
Founded: Sandwich United Kingdom (2012)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2017
NCT03227796
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Levicept

Active Ingredients

Drugs in Phase 2 Trials (1)

levi-04 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1